Komori
Statutory disclosure document4889Renascience Inc.Pharmaceuticals

Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares)

The 263,400 shares allotted in a third-party allotment on 26 March 2026 changed from CVI Investments, Inc., the allottee, to BofA Securities Co., Ltd. in an off-auction transaction.

Worth reading
60In focus
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
304490400
Yen (total transfer amount)
Wording
Definitive
How definitive the wording is.

Decision and Details

Transfer of shares allotted through a third-party allotment

Implementation14 September 2026 (actual)
AmountTotal transfer price: ¥304,490,400; ¥1,156 per share
Quantity / scale263,400 shares
Reason

For the purpose of moving the shares to a swap position

Decision and Details
ItemDetails
Matter CoveredTransfer of shares allotted through a third-party allotment
Implementation Date14 September 2026 (actual)
AmountTotal transfer price: ¥304,490,400; ¥1,156 per share
Quantity / scale263,400 shares
ReasonFor the purpose of moving the shares to a swap position
Related previous disclosuresThe Company's shares allotted through a third-party allotment on 26 March 2026 (title: Not disclosed)
Items this document does not state (6)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleFuture plans

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the purpose of moving the shares to a swap position.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares) | Renascience Inc. (4889) timely disclosure | Komori